Research Directory

Engineering immune cell therapies: will in vivo approaches replace current therapies?

Read more

EU medicines regulators agree AI workplan

Read more

Private finance, alliances drive Swiss biotech

Read more

Biopharma 2025 forecasts focus on portfolio growth

Read more

Editorial: Stand up for the FDA

Read more

Targeted protein degradation: Scientists are looking inside the cell for new drug targets

Read more

EU public policy on AI

Read more

BioPharma updates 2025 forecasts with some cautions

Read more

Antimicrobial Review: Drug-resistant infections are the silent pandemic

Read more

Oncology Review: New targets for challenging diseases

Read more